An Australian stem cell and regenerative medicine company

ASX Announcements

03 Oct 2019 CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial
27 Sep 2019 Notification of 2019 Annual General Meeting Date
26 Sep 2019 Cynata Receives US$3 million Fujifilm License Fee
18 Sep 2019 Cleansing Notice
18 Sep 2019 Appendix 3B-Exercise of Options
17 Sep 2019 Fujifilm Exercises License Option in GvHD
09 Sep 2019 Expiry of Voluntary Escrow Arrangement
04 Sep 2019 Cynata transplant rejection study accepted for publication
03 Sep 2019 Cleansing Notice
03 Sep 2019 Appendix 3B-Exercise of Options
27 Aug 2019 Cleansing Notice
27 Aug 2019 Appendix 3B-Exercise of Options
23 Aug 2019 Appendix 4G
23 Aug 2019 Appendix 4E & Annual Report
15 Aug 2019 Cleansing Notice
15 Aug 2019 Appendix 3B-Exercise of Options
15 Aug 2019 Update on Discussions with Sumitomo and Fujifilm
02 Aug 2019 Cleansing Notice
02 Aug 2019 Appendix 3B-Exercise of Options
24 Jul 2019 Response to ASX Aware Query
19 Jul 2019 Response to ASX Price and Volume Query
19 Jul 2019 Cynata confirms receipt of indicative non-binding proposal
17 Jul 2019 Trading Halt
04 Jul 2019 2019 Quarterly Report
30 May 2019 Cynata's Cymerus Technology Featured in ISCT Presentations
20 May 2019 Appendix 3Z-Dr John Chiplin
20 May 2019 Appendix 3X-Dr Geoff Brooke
20 May 2019 Appendix 3B
20 May 2019 Cynata Strengthens Board & Executive Management Team
07 May 2019 Appendix 3Y-Dr John Chiplin
07 May 2019 Cleansing Notice
07 May 2019 Appendix 3B-Exercise of Options
06 May 2019 CYP Progresses Start-Up Activities for Clinical Trial in CLI
26 Apr 2019 March 2019 Quarterly Report
04 Apr 2019 European Patent Issued to Cynata Therapeutics
21 Mar 2019 Extension of FUJIFILM Licence Option in GvHD
21 Mar 2019 Cleansing Notice
21 Mar 2019 Cynata Extends FUJIFILM Licence Option in GvHD
20 Mar 2019 Appendix 3B-Exercise of Options
19 Mar 2019 Trading Halt
13 Mar 2019 Cleansing Notice
13 Mar 2019 Appendix 3B-Exercise of Options
12 Mar 2019 Cynata Receives Favourable Advice on Planned CLI Trial
11 Mar 2019 Joint Study of Cynata MSCs receives VMRAF Funding
04 Mar 2019 Positive Pre-Clinical Coronary Artery Disease Data for CYP
27 Feb 2019 Appendix 4D & Half-Year Financial Statements
25 Feb 2019 Further Cynata Asthma Study Published
22 Feb 2019 Cleansing Notice
22 Feb 2019 Appendix 3B-Exercise of Options
18 Feb 2019 Cleansing Notice